MATEON THERAPEUTICS INC Human Resources Contracts & Agreements
62 Contracts & Agreements
- Bonus & Incentive Agreements (6 contracts)
- Compensation Agreements (7)
- Consulting Agreements (6)
- Employment Agreements (34)
- Separation Agreements (9)
- Independent consulting agreement between Oncotelic Therapeutics, Inc. and Seymour Fein, MD dated May 1, 2022 (Filed With SEC on May 6, 2022)
- Independent consulting agreement between Oncotelic Therapeutics, Inc. and Fatih Uckun, MD, Ph.D. dated May 1, 2022 (Filed With SEC on May 6, 2022)
- Consulting Agreement by and between the Company and Dr. Maida, dated May 5, 2020 (Filed With SEC on June 22, 2020)
- Consulting Agreement by and between the Company and Artius, dated March 9, 2020 (Filed With SEC on June 22, 2020)
- Employment Agreement dated August 23, 2019 between the Company and Dr. Fatih Uckun (Filed With SEC on November 25, 2019)
- Agreement for Delivery and Licensed Use of WideTrial Bonus Dataset (Data License 2 Agreement) dated September 5, 2019 between WideTrial and Oncotelic (Filed With SEC on September 10, 2019)
- Employment Agreement dated August 23, 2019 between the Company and Mr. Amit Shah (Filed With SEC on August 29, 2019)
- Employment Agreement dated August 23, 2019 between the Company and Dr. Chulho Park (Filed With SEC on August 29, 2019)
- Employment Agreement dated August 23, 2019 between the Company and Dr. Fatih Uckun (Filed With SEC on August 29, 2019)
- Employment Agreement dated August 23, 2019 between the Company and Dr. Vuong Trieu (Filed With SEC on August 29, 2019)
- Separation Agreement dated as of July 1, 2019 by and between the Company and Matthew M. Loar (Filed With SEC on July 5, 2019)
- Separation and Release Agreement, dated April 17, 2019, by and between the Company and William D. Schwieterman, M.D (Filed With SEC on April 18, 2019)
- Amendment No. 1 to Second Amended and Restated Employment Agreement by and between the Registrant and David J. Chaplin, dated as of October 2, 2017 (Filed With SEC on November 14, 2017)
- Amendment No. 1 to Employment Agreement by and between the Registrant and Matthew M. Loar, dated as of October 2, 2017 (Filed With SEC on November 14, 2017)
- Amendment No. 2 to Employment Agreement by and between the Registrant and William D. Schwieterman, dated as of October 2, 2017 (Filed With SEC on November 14, 2017)
- AMENDED AND RESTATED MATEON THERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN (as amended and restated on January 12, 2017) (Filed With SEC on January 13, 2017)
- MATEON THERAPEUTICS, INC. Stock Option Grant Notice Stock Option Grant under the Companys 2017 Equity Incentive Plan (Filed With SEC on January 13, 2017)
- MATEON THERAPEUTICS, INC. 2017 EQUITY INCENTIVE PLAN (Filed With SEC on January 13, 2017)
- MATEON THERAPEUTICS, INC. AMENDED AND RESTATED DIRECTOR COMPENSATION POLICY AS IN EFFECT OCTOBER 25, 2016 (Filed With SEC on October 28, 2016)
- SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on October 28, 2016)
- AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on August 6, 2015)
- OXiGENE, INC. StockOption Grant Notice Stock Option Grant under the Companys 2015 Equity Incentive Plan (Filed With SEC on August 6, 2015)
- SEPARATION AGREEMENT AND RELEASE (Filed With SEC on August 6, 2015)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 6, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 6, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 6, 2015)
- CONSULTING AGREEMENT (Filed With SEC on November 13, 2014)
- EMPLOYMENT AGREEMENT AMENDMENT (Filed With SEC on November 13, 2014)
- OXiGENE, INC. AMENDEDAND RESTATED DIRECTOR COMPENSATION POLICY (Filed With SEC on August 8, 2014)
- SEPARATION AGREEMENT AND RELEASE (Filed With SEC on August 8, 2014)
- AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on August 8, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 8, 2014)
- CONSULTING AGREEMENT (Filed With SEC on January 23, 2013)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 28, 2012)
- Ex-10.1 Employment Agreement by and among OXiGENE and Dr. Peter Langecker, dated as of June 10, 2009 (Filed With SEC on June 17, 2009)
- EX-10.1 SEPARATION AGREEMENT BETWEEN OXIGENE AND DR. WALICKE DATED AS OF JUNE 10, 2009 (Filed With SEC on June 12, 2009)
- EX-10.56 AMENDMENT NO 2 TO EMPLOYMENT AGREEMENT MR. MURPHY (Filed With SEC on March 30, 2009)
- EX-10.55 AMENDMENT NO 2 TO EMPLOYMENT AGREEMENT DR. CHAPLIN (Filed With SEC on March 30, 2009)
- EX-10.54 409A AMENDMENT TO EMPLOYMENT AGREEMENT DR. WALICKE (Filed With SEC on March 30, 2009)
- EX-10.53 409A AMENDMENT TO EMPLOYMENT AGREEMENT MR. MURPHY (Filed With SEC on March 30, 2009)
